Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Schrödinger, Inc. (SDGR)

Akinsanya Karen — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Mar 2, 2026
Sale
Shares
2,206
Price
$11.99
Total Value
$26.45K
Shares Held After
71,322
% of Holdings
3.0%

AbbVie Inc. (ABBV)

Siatis Perry C — EVP, GC AND SECRETARY
Mar 2, 2026
Sale
Shares
2,600
Price
$235.26
Total Value
$611.68K
Shares Held After
4,619
% of Holdings
36.0%

AbbVie Inc. (ABBV)

Siatis Perry C — EVP, GC AND SECRETARY
Mar 2, 2026
Sale
Shares
10,291
Price
$234.66
Total Value
$2.41M
Shares Held After
7,219
% of Holdings
58.8%

AbbVie Inc. (ABBV)

Siatis Perry C — EVP, GC AND SECRETARY
Mar 2, 2026
Sale
Shares
5,777
Price
$233.51
Total Value
$1.35M
Shares Held After
17,510
% of Holdings
24.8%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,163
Price
$28.96
Total Value
$33.68K
Shares Held After
44,086
% of Holdings
2.6%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
41,329
% of Holdings
2.8%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
38,516
% of Holdings
4.2%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
34,531
% of Holdings
3.3%

agilon health, inc. (AGL)

Shaker Benjamin — Chief Markets Officer
Mar 2, 2026
Purchase
Shares
500,000
Price
$0.60
Total Value
$301.05K
Shares Held After
1,367,674
% of Holdings
36.6%

Liquidia Corp (LQDA)

Moomaw Scott — Chief Commercial Officer
Mar 2, 2026
Sale
Shares
827
Price
$30.58
Total Value
$25.29K
Shares Held After
188,954
% of Holdings
0.4%
Mar 2, 2026
Purchase
Shares
7,534
Price
$2.90
Total Value
$21.85K
Shares Held After
8,292
% of Holdings
90.9%
Mar 2, 2026
Sale
Shares
5,000
Price
$61.21
Total Value
$306.05K
Shares Held After
17,933
% of Holdings
21.8%

Claritev Corp (CTEV)

O'Neil Tara — SVP, General Counsel
Mar 2, 2026
Purchase
Shares
750
Price
$12.99
Total Value
$9.74K
Shares Held After
27,199
% of Holdings
2.8%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
886
Price
$61.62
Total Value
$54.60K
Shares Held After
50,440
% of Holdings
1.7%
Mar 2, 2026
Sale
Shares
1,183
Price
$427.21
Total Value
$505.39K
Shares Held After
9,257
% of Holdings
11.3%
Mar 2, 2026
Sale
Shares
443,707
Price
$33.25
Total Value
$14.75M
Shares Held After
174,144
% of Holdings
71.8%

Edwards Lifesciences Corp (EW)

BOBO DONALD E JR — CVP,Strategy/Corp Development
Mar 2, 2026
Sale
Shares
11,340
Price
$85.93
Total Value
$974.43K
Shares Held After
21,266
% of Holdings
34.8%

Monte Rosa Therapeutics, Inc. (GLUE)

Dunn Edmund — Principal Accounting Officer
Mar 2, 2026
Sale
Shares
536
Price
$17.50
Total Value
$9.38K
Shares Held After
22,693
% of Holdings
2.3%
Mar 2, 2026
Sale
Shares
55,930
Price
$107.81
Total Value
$6.03M
Shares Held After
1,476,500
% of Holdings
3.6%

TransMedics Group, Inc. (TMDX)

Hernandez Gerardo — Chief Financial Officer
Mar 2, 2026
Sale
Shares
375
Price
$139.12
Total Value
$52.17K
Shares Held After
14,689
% of Holdings
2.5%

TransMedics Group, Inc. (TMDX)

Ranganath Anil P. — Senior Vice President, General Counsel and Secretary
Mar 2, 2026
Sale
Shares
864
Price
$139.12
Total Value
$120.20K
Shares Held After
13,091
% of Holdings
6.2%

TransMedics Group, Inc. (TMDX)

Corcoran Nicholas — SVP of Supply Chain and Operations
Mar 2, 2026
Sale
Shares
2,966
Price
$139.12
Total Value
$412.63K
Shares Held After
29,831
% of Holdings
9.0%

Alkermes plc. (ALKS)

Parisi Samuel Joseph — VP, Finance (Interim PAO)
Mar 2, 2026
Sale
Shares
6,890
Price
$29.29
Total Value
$201.81K
Shares Held After
7,717
% of Holdings
47.2%

Alkermes plc. (ALKS)

Nichols Christian Todd — SVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
6,000
Price
$30.00
Total Value
$180.00K
Shares Held After
109,769
% of Holdings
5.2%

Adaptive Biotechnologies Corp (ADPT)

ROBINS HARLAN S — Chief Scientific Officer
Mar 2, 2026
Sale
Shares
10,000
Price
$15.72
Total Value
$157.20K
Shares Held After
1,169,524
% of Holdings
0.8%
Mar 2, 2026
Sale
Shares
22,500
Price
$14.35
Total Value
$322.84K
Shares Held After
998,680
% of Holdings
2.2%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane — Chief Financial Officer
Mar 2, 2026
Sale
Shares
406
Price
$71.66
Total Value
$29.09K
Shares Held After
181,371
% of Holdings
0.2%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane — Chief Financial Officer
Mar 2, 2026
Sale
Shares
994
Price
$70.45
Total Value
$70.03K
Shares Held After
181,777
% of Holdings
0.5%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane — Chief Financial Officer
Mar 2, 2026
Sale
Shares
300
Price
$69.43
Total Value
$20.83K
Shares Held After
182,771
% of Holdings
0.2%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane — Chief Financial Officer
Mar 2, 2026
Sale
Shares
300
Price
$68.27
Total Value
$20.48K
Shares Held After
183,071
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
36,606
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
36,643
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
36,737
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
36,818
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
36,988
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
37,088
% of Holdings
0.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
37,417
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
37,809
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
38,067
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
38,157
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
160
Price
$332.64
Total Value
$53.22K
Shares Held After
98,628
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
399
Price
$331.93
Total Value
$132.44K
Shares Held After
98,788
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
346
Price
$330.85
Total Value
$114.47K
Shares Held After
99,187
% of Holdings
0.3%
Mar 2, 2026
Sale
Shares
722
Price
$329.71
Total Value
$238.05K
Shares Held After
99,533
% of Holdings
0.7%
Mar 2, 2026
Sale
Shares
424
Price
$328.71
Total Value
$139.37K
Shares Held After
100,255
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
1,399
Price
$327.67
Total Value
$458.41K
Shares Held After
100,679
% of Holdings
1.4%
Mar 2, 2026
Sale
Shares
1,669
Price
$326.81
Total Value
$545.45K
Shares Held After
102,078
% of Holdings
1.6%
Mar 2, 2026
Sale
Shares
1,098
Price
$325.63
Total Value
$357.54K
Shares Held After
103,747
% of Holdings
1.0%
Mar 2, 2026
Sale
Shares
382
Price
$324.65
Total Value
$124.02K
Shares Held After
104,845
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
200
Price
$323.62
Total Value
$64.72K
Shares Held After
105,227
% of Holdings
0.2%
Version: v26.3.33